. 2020 May 21;6(5):e03989. doi: 10.1016/j.heliyon.2020.e03989

Table 3.

Effect of hexane fraction of Kigelia africana fruit on fasting blood glucose levels.

Treatment	Fasting Blood Glucose (mg/dL)
Treatment	Initial FBS (mg/dL)	Final FBS (mg/dL)	Percentage Output (%)
Group A	77.80 ± 3.47	95.20 ± 1.25	22.37 ± 2.22^↑
Group B	262.40 ± 3.03	480.40 ± 4.82^{α, β, ɣ}	83.08 ± 1.79^↑
Group C	341.61 ± 13.77	246.20 ± 12.88 ^{α, β, ɣ}	27.92 ± 0.89^↓
Group D	460.20 ± 31.92	223.40 ± 51.02 ^{α, β}	51.46 ± 0.90^↓
Group E	339.00 ± 12.05	145.60 ± 8.52	57.05 ± 2.47^↓
Group F	401.80 ± 20.05	110.6 ± 2.89 ^α	72.47 ± 1.89^↓

Values are presented as Mean ± SEM (n = 5). Means ± SEM with different superscript letters (α, β, ɣ) within the column indicate significant difference at p ≤ 0.05, p ≤ 0.01 and p ≤ 0.001 respectively and (^↑↓) within the column indicate a percentage increase and decrease.

Keys: Group A = Normal Control Group with Citrate Buffer Only; Group B = Diabetic Group Only; Group C = Diabetic Group +100 mg/kg B. W. Hexane Fraction of Kigelia africana Fruit Extract; Group D = Diabetic Group +200 mg/kg B. W. Hexane Fraction of Kigelia africana Fruit Extract; Group E = Diabetic Group +400 mg/kg B. W. Hexane Fraction of Kigelia africana Fruit Extract; Group F = Diabetic Group +10 mg/kg B. W. Glibenclamide.